See also this year's filing and all EDGAR filings for this company.
PDF Report 0000872589_2013_Regeneron_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0000872589, Regeneron Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,206,012,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 379,940,000 |
| 3 | remainder_Assets | 494,538,000 |
| 4 | LiabilitiesCurrent | 163,550,000 |
| 5 | LiabilitiesNoncurrent | 7,259,000 |
| 6 | remainder_Liabilities | 664,296,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 210,755,000 |
| 9 | ResearchAndDevelopmentExpense | 625,554,000 |
| 10 | remainder_Expenses | -251,393,000 |
| 11 | remainder_Revenues | 1,378,477,000 |
| 12 | remainder_NetIncome | -43,292,000 |
| 13 | remainder_ComprehensiveNetIncome | 696,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,080,490,000 |
| 1 | Liabilities | 835,105,000 |
| 2 | Expenses | 584,916,000 |
| 3 | Revenues | 1,378,477,000 |
| 4 | StockholdersEquity | 1,245,385,000 |
| 5 | NetIncome | 750,269,000 |
| 6 | ComprehensiveNetIncome | 750,617,000 |
| 7 | BaseVar | 2,461,488,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.38 |
| 9 | EconomicCapitalRatio | 3.27 |
Edgar->Model Mapping
Feature Distribution
Change over Time
